Voloridge Investment Management, LLC Forma Therapeutics Holdings, Inc. Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $165,568 - $470,660	23,254 New	23,254 $464,000
Q4 2021 Feb 14, 2022	SELL	$13.6 - $24.89 $962,594 - $1.76 Million	-70,779 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$21.22 - $25.7 $781,659 - $946,685	-36,836 Reduced 34.23%	70,779 $1.64 Million
Q2 2021 Aug 16, 2021	BUY	$22.86 - $30.95 $1.09 Million - $1.48 Million	47,713 Added 79.65%	107,615 $2.68 Million
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $950,213 - $1.66 Million	38,658 Added 181.97%	59,902 $1.68 Million
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $741,415 - $1.09 Million	21,244 New	21,244 $741,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.